J.P. Morgan Private Wealth Advisors’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $623K | Buy |
54,329
+203
| +0.4% | +$2.33K | ﹤0.01% | 1152 |
|
|
2023
Q2 | $1.37M | Sell |
54,126
-1,684
| -3% | -$42.6K | 0.01% | 673 |
|
|
2023
Q1 | $1.8M | Buy |
55,810
+21,689
| +64% | +$699K | ﹤0.01% | 920 |
|
|
2022
Q4 | $630K | Sell |
34,121
-3,386
| -9% | -$62.5K | ﹤0.01% | 1367 |
|
|
2022
Q3 | $1.01M | Buy |
37,507
+9,529
| +34% | +$257K | ﹤0.01% | 1130 |
|
|
2022
Q2 | $387K | Sell |
27,978
-57,167
| -67% | -$791K | ﹤0.01% | 1550 |
|
|
2022
Q1 | $1.66M | Sell |
85,145
-27,299
| -24% | -$532K | ﹤0.01% | 979 |
|
|
2021
Q4 | $1.84M | Sell |
112,444
-52,662
| -32% | -$859K | ﹤0.01% | 942 |
|
|
2021
Q3 | $4.6M | Buy |
165,106
+10,756
| +7% | +$300K | 0.01% | 613 |
|
|
2021
Q2 | $4.58M | Buy |
154,350
+71,905
| +87% | +$2.13M | 0.01% | 616 |
|
|
2021
Q1 | $2.3M | Buy |
82,445
+38,251
| +87% | +$1.07M | 0.01% | 722 |
|
|
2020
Q4 | $1.25M | Sell |
44,194
-6,154
| -12% | -$174K | ﹤0.01% | 922 |
|
|
2020
Q3 | $1.27M | Sell |
50,348
-3,942
| -7% | -$99.1K | ﹤0.01% | 797 |
|
|
2020
Q2 | $1.33M | Buy |
54,290
+21,902
| +68% | +$535K | 0.01% | 705 |
|
|
2020
Q1 | $479K | Buy |
32,388
+14,038
| +77% | +$208K | ﹤0.01% | 943 |
|
|
2019
Q4 | $298K | Buy |
18,350
+3,708
| +25% | +$60.2K | ﹤0.01% | 1245 |
|
|
2019
Q3 | $190K | Buy |
14,642
+3,625
| +33% | +$47K | ﹤0.01% | 1352 |
|
|
2019
Q2 | $143K | Buy |
+11,017
| New | +$143K | ﹤0.01% | 1320 |
|